Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypogonadism | 28 | 2022 | 798 | 2.690 |
Why?
|
Testosterone | 29 | 2022 | 2401 | 1.890 |
Why?
|
Gonadotropin-Releasing Hormone | 22 | 2019 | 1185 | 1.450 |
Why?
|
Luteinizing Hormone | 18 | 2019 | 864 | 1.050 |
Why?
|
Follicle Stimulating Hormone | 12 | 2010 | 738 | 1.050 |
Why?
|
Turner Syndrome | 5 | 2021 | 130 | 0.760 |
Why?
|
Gonadotropins | 8 | 2010 | 241 | 0.720 |
Why?
|
Klinefelter Syndrome | 1 | 2019 | 49 | 0.690 |
Why?
|
Hormone Replacement Therapy | 7 | 2022 | 744 | 0.650 |
Why?
|
Neurosecretory Systems | 6 | 2019 | 231 | 0.630 |
Why?
|
Inhibins | 8 | 2013 | 211 | 0.550 |
Why?
|
Receptors, LHRH | 8 | 2009 | 159 | 0.530 |
Why?
|
Gonadal Steroid Hormones | 6 | 2010 | 711 | 0.520 |
Why?
|
Performance-Enhancing Substances | 1 | 2014 | 29 | 0.490 |
Why?
|
Androgens | 6 | 2019 | 1271 | 0.470 |
Why?
|
Hypothalamus | 4 | 2010 | 1063 | 0.420 |
Why?
|
Spermatogenesis | 2 | 2012 | 262 | 0.410 |
Why?
|
Estradiol | 8 | 2010 | 2021 | 0.400 |
Why?
|
Polycystic Ovary Syndrome | 5 | 2015 | 369 | 0.370 |
Why?
|
Pituitary Gland | 3 | 2010 | 665 | 0.360 |
Why?
|
Kallmann Syndrome | 10 | 2010 | 140 | 0.360 |
Why?
|
Hyperthyroidism | 1 | 2012 | 293 | 0.350 |
Why?
|
Sex Hormone-Binding Globulin | 5 | 2022 | 548 | 0.320 |
Why?
|
Iodine Radioisotopes | 1 | 2012 | 1030 | 0.320 |
Why?
|
DNA Nucleotidyltransferases | 2 | 1999 | 193 | 0.320 |
Why?
|
Insulin Resistance | 4 | 2019 | 3861 | 0.310 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 7 | 2009 | 250 | 0.270 |
Why?
|
Integrases | 2 | 1999 | 533 | 0.270 |
Why?
|
Leydig Cells | 1 | 2005 | 56 | 0.260 |
Why?
|
Menstrual Cycle | 2 | 2008 | 551 | 0.260 |
Why?
|
Hormone Antagonists | 3 | 2001 | 107 | 0.250 |
Why?
|
Androgen-Insensitivity Syndrome | 1 | 2004 | 31 | 0.240 |
Why?
|
Aromatase Inhibitors | 3 | 2007 | 491 | 0.240 |
Why?
|
Reproduction | 3 | 2013 | 668 | 0.240 |
Why?
|
Oxidative Phosphorylation | 1 | 2005 | 480 | 0.220 |
Why?
|
Human Growth Hormone | 2 | 1999 | 683 | 0.210 |
Why?
|
Testis | 6 | 2013 | 800 | 0.210 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2007 | 633 | 0.210 |
Why?
|
Eunuchism | 1 | 2001 | 19 | 0.200 |
Why?
|
Karyotyping | 2 | 2021 | 1243 | 0.190 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2021 | 31 | 0.190 |
Why?
|
Glucose | 1 | 2013 | 4391 | 0.190 |
Why?
|
Dipeptides | 2 | 2000 | 409 | 0.180 |
Why?
|
Ketoconazole | 3 | 2007 | 95 | 0.180 |
Why?
|
Survivors | 1 | 2010 | 2286 | 0.170 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 1 | 1999 | 98 | 0.170 |
Why?
|
DNA Topoisomerases, Type I | 1 | 1999 | 102 | 0.170 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11039 | 0.170 |
Why?
|
Oxygen Consumption | 1 | 2005 | 1869 | 0.160 |
Why?
|
Male | 53 | 2022 | 349538 | 0.160 |
Why?
|
Substance-Related Disorders | 1 | 2014 | 4250 | 0.160 |
Why?
|
Eukaryotic Cells | 1 | 1999 | 198 | 0.160 |
Why?
|
Adult | 44 | 2022 | 213712 | 0.160 |
Why?
|
Mosaicism | 1 | 2021 | 440 | 0.160 |
Why?
|
Extracellular Matrix Proteins | 5 | 2012 | 849 | 0.150 |
Why?
|
Receptors, Androgen | 1 | 2004 | 1057 | 0.150 |
Why?
|
Virilism | 1 | 1997 | 31 | 0.150 |
Why?
|
Homozygote | 2 | 2001 | 1777 | 0.150 |
Why?
|
Blood Chemical Analysis | 2 | 2018 | 440 | 0.150 |
Why?
|
Diabetes Complications | 2 | 1995 | 1359 | 0.150 |
Why?
|
Humans | 75 | 2022 | 742088 | 0.140 |
Why?
|
Hypopituitarism | 1 | 1999 | 254 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2019 | 11695 | 0.140 |
Why?
|
Growth Hormone | 1 | 1999 | 703 | 0.140 |
Why?
|
Stress, Physiological | 1 | 2004 | 1402 | 0.140 |
Why?
|
Periodicity | 1 | 1998 | 363 | 0.140 |
Why?
|
Ovarian Cysts | 1 | 1997 | 115 | 0.140 |
Why?
|
Fertility | 1 | 2001 | 770 | 0.140 |
Why?
|
Genes, BRCA1 | 1 | 2000 | 780 | 0.140 |
Why?
|
Mutagenesis | 1 | 2000 | 1263 | 0.140 |
Why?
|
Goiter | 1 | 1996 | 86 | 0.130 |
Why?
|
Cystic Fibrosis | 2 | 1995 | 1178 | 0.130 |
Why?
|
Thyrotoxicosis | 1 | 1996 | 82 | 0.130 |
Why?
|
Migraine Disorders | 1 | 2008 | 1620 | 0.130 |
Why?
|
Renin-Angiotensin System | 2 | 1997 | 759 | 0.130 |
Why?
|
Valproic Acid | 2 | 2008 | 446 | 0.130 |
Why?
|
Pituitary Diseases | 1 | 1996 | 141 | 0.130 |
Why?
|
Aldosterone | 2 | 1997 | 876 | 0.130 |
Why?
|
Mutagenesis, Insertional | 1 | 1997 | 655 | 0.130 |
Why?
|
Pedigree | 11 | 2010 | 4646 | 0.130 |
Why?
|
Insulin | 2 | 2010 | 6575 | 0.130 |
Why?
|
Phenotype | 11 | 2021 | 16331 | 0.120 |
Why?
|
Orchiectomy | 2 | 2010 | 466 | 0.120 |
Why?
|
Oligopeptides | 2 | 2010 | 1176 | 0.120 |
Why?
|
Blood Glucose | 3 | 2010 | 6249 | 0.120 |
Why?
|
Follicle Stimulating Hormone, Human | 1 | 2013 | 25 | 0.120 |
Why?
|
Abdominal Muscles | 1 | 1994 | 162 | 0.120 |
Why?
|
Transcriptional Activation | 1 | 2000 | 1782 | 0.120 |
Why?
|
Oxygen | 1 | 2005 | 4169 | 0.110 |
Why?
|
Mutation | 15 | 2012 | 29717 | 0.110 |
Why?
|
Hyperprolactinemia | 2 | 2008 | 129 | 0.110 |
Why?
|
Puberty, Delayed | 4 | 2009 | 115 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2000 | 1145 | 0.110 |
Why?
|
Estrogens | 1 | 2000 | 1562 | 0.110 |
Why?
|
Renal Dialysis | 1 | 2022 | 1780 | 0.110 |
Why?
|
Epilepsy | 2 | 2008 | 3301 | 0.110 |
Why?
|
Feedback | 3 | 2001 | 793 | 0.110 |
Why?
|
Estrogen Replacement Therapy | 1 | 2019 | 1202 | 0.110 |
Why?
|
Enzyme Inhibitors | 2 | 2001 | 3800 | 0.110 |
Why?
|
Postmenopause | 2 | 2003 | 2461 | 0.110 |
Why?
|
Edema | 1 | 1997 | 790 | 0.110 |
Why?
|
Ovary | 1 | 1997 | 981 | 0.110 |
Why?
|
Mitochondria | 1 | 2005 | 3520 | 0.100 |
Why?
|
Endocrinology | 1 | 2018 | 443 | 0.100 |
Why?
|
Body Composition | 4 | 2010 | 2400 | 0.100 |
Why?
|
Prevalence | 3 | 2019 | 15194 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2008 | 1221 | 0.100 |
Why?
|
Genetic Counseling | 1 | 2015 | 600 | 0.100 |
Why?
|
Liver Diseases | 1 | 2019 | 1252 | 0.100 |
Why?
|
Diabetic Neuropathies | 1 | 1994 | 410 | 0.090 |
Why?
|
Odds Ratio | 2 | 2022 | 9846 | 0.090 |
Why?
|
Bipolar Disorder | 1 | 2008 | 5024 | 0.090 |
Why?
|
Sexual Maturation | 1 | 2012 | 265 | 0.090 |
Why?
|
Molecular Sequence Data | 8 | 2007 | 18112 | 0.090 |
Why?
|
Seminiferous Tubules | 1 | 2009 | 26 | 0.090 |
Why?
|
Infertility, Male | 1 | 2013 | 407 | 0.090 |
Why?
|
Puberty | 3 | 2009 | 489 | 0.090 |
Why?
|
Mutation, Missense | 3 | 2019 | 2556 | 0.090 |
Why?
|
Hypothalamo-Hypophyseal System | 3 | 2010 | 703 | 0.090 |
Why?
|
Aging | 3 | 2018 | 8626 | 0.080 |
Why?
|
Infertility, Female | 1 | 2015 | 784 | 0.080 |
Why?
|
Recombinases | 2 | 1999 | 67 | 0.080 |
Why?
|
Seminiferous Epithelium | 1 | 2008 | 9 | 0.080 |
Why?
|
Middle Aged | 21 | 2022 | 213127 | 0.080 |
Why?
|
Hyperandrogenism | 1 | 2008 | 38 | 0.080 |
Why?
|
Bacterial Proteins | 2 | 1999 | 3843 | 0.080 |
Why?
|
Feedback, Physiological | 2 | 2008 | 479 | 0.080 |
Why?
|
Lymphocytes | 1 | 1996 | 2614 | 0.080 |
Why?
|
Gastrointestinal Hormones | 1 | 2008 | 97 | 0.080 |
Why?
|
Genetic Testing | 1 | 2021 | 3439 | 0.080 |
Why?
|
Conserved Sequence | 3 | 2007 | 1202 | 0.080 |
Why?
|
Ovulation | 1 | 2008 | 189 | 0.080 |
Why?
|
Population Surveillance | 1 | 2018 | 2616 | 0.080 |
Why?
|
Olfaction Disorders | 3 | 2006 | 222 | 0.080 |
Why?
|
Amino Acid Sequence | 6 | 2007 | 13814 | 0.070 |
Why?
|
Athletes | 1 | 2014 | 1092 | 0.070 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2007 | 361 | 0.070 |
Why?
|
Reference Values | 5 | 2015 | 4982 | 0.070 |
Why?
|
Receptors, Peptide | 1 | 2008 | 272 | 0.070 |
Why?
|
Nerve Tissue Proteins | 5 | 2012 | 4465 | 0.070 |
Why?
|
Aged | 15 | 2022 | 162944 | 0.070 |
Why?
|
Young Adult | 8 | 2022 | 56350 | 0.070 |
Why?
|
Triazines | 1 | 2008 | 316 | 0.070 |
Why?
|
Nitriles | 2 | 2001 | 952 | 0.070 |
Why?
|
Remission, Spontaneous | 2 | 2007 | 380 | 0.070 |
Why?
|
Partial Pressure | 1 | 2005 | 253 | 0.070 |
Why?
|
Glucocorticoids | 3 | 2006 | 2107 | 0.060 |
Why?
|
Adipokines | 1 | 2007 | 318 | 0.060 |
Why?
|
Administration, Oral | 1 | 2013 | 3913 | 0.060 |
Why?
|
Triazoles | 2 | 2001 | 907 | 0.060 |
Why?
|
Glucose Clamp Technique | 1 | 2005 | 266 | 0.060 |
Why?
|
Sperm Count | 3 | 2013 | 216 | 0.060 |
Why?
|
Adolescent | 14 | 2019 | 85649 | 0.060 |
Why?
|
Carcinoma | 1 | 1996 | 2374 | 0.060 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2004 | 185 | 0.060 |
Why?
|
Amenorrhea | 1 | 2008 | 485 | 0.060 |
Why?
|
Immunoassay | 1 | 2007 | 752 | 0.060 |
Why?
|
Female | 30 | 2021 | 379592 | 0.060 |
Why?
|
Waist-Hip Ratio | 1 | 2005 | 517 | 0.060 |
Why?
|
Recombination, Genetic | 2 | 1999 | 1586 | 0.060 |
Why?
|
Plasmids | 2 | 2000 | 2305 | 0.060 |
Why?
|
Radiotherapy | 1 | 2010 | 1525 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2004 | 11690 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 1996 | 2274 | 0.050 |
Why?
|
Neuropeptides | 1 | 2008 | 942 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 1996 | 2861 | 0.050 |
Why?
|
Hyperinsulinism | 1 | 2005 | 415 | 0.050 |
Why?
|
Public Health | 1 | 2014 | 2594 | 0.050 |
Why?
|
Glucose Intolerance | 1 | 2005 | 577 | 0.050 |
Why?
|
Gonadotropins, Pituitary | 1 | 2000 | 73 | 0.050 |
Why?
|
Estrogen Antagonists | 1 | 2001 | 151 | 0.050 |
Why?
|
Bromocriptine | 1 | 2000 | 111 | 0.050 |
Why?
|
DAX-1 Orphan Nuclear Receptor | 3 | 2009 | 29 | 0.050 |
Why?
|
Giant Cell Arteritis | 1 | 2004 | 292 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2010 | 10943 | 0.040 |
Why?
|
Prednisone | 1 | 2004 | 1567 | 0.040 |
Why?
|
Chorionic Gonadotropin | 1 | 2001 | 474 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39004 | 0.040 |
Why?
|
beta-Galactosidase | 1 | 2000 | 573 | 0.040 |
Why?
|
Time Factors | 5 | 2012 | 40054 | 0.040 |
Why?
|
Secretory Rate | 1 | 1998 | 82 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2022 | 977 | 0.040 |
Why?
|
Radiography | 1 | 2010 | 7010 | 0.040 |
Why?
|
Chromosomes, Human, Y | 1 | 2019 | 148 | 0.040 |
Why?
|
Point Mutation | 1 | 2004 | 1624 | 0.040 |
Why?
|
Genotype | 6 | 2009 | 12946 | 0.040 |
Why?
|
Repressor Proteins | 2 | 2000 | 3020 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2000 | 711 | 0.040 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2018 | 45 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 4566 | 0.040 |
Why?
|
Base Sequence | 4 | 2007 | 12797 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2019 | 528 | 0.040 |
Why?
|
Anticonvulsants | 1 | 2008 | 1914 | 0.040 |
Why?
|
Pulsatile Flow | 1 | 1999 | 332 | 0.040 |
Why?
|
Body Water | 1 | 1999 | 343 | 0.040 |
Why?
|
Body Mass Index | 2 | 2022 | 12695 | 0.040 |
Why?
|
Androstenedione | 1 | 1997 | 131 | 0.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2004 | 1659 | 0.040 |
Why?
|
Binding Sites | 2 | 2004 | 6115 | 0.040 |
Why?
|
Bone and Bones | 1 | 2008 | 2575 | 0.040 |
Why?
|
Catalytic Domain | 1 | 1999 | 699 | 0.040 |
Why?
|
Leptin | 1 | 2005 | 1593 | 0.040 |
Why?
|
Models, Molecular | 3 | 2007 | 5454 | 0.040 |
Why?
|
Ligands | 1 | 2004 | 3293 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2000 | 1723 | 0.040 |
Why?
|
Nifedipine | 1 | 1997 | 226 | 0.040 |
Why?
|
Prospective Studies | 4 | 2008 | 53187 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2013 | 6608 | 0.030 |
Why?
|
Evidence-Based Medicine | 3 | 2018 | 3611 | 0.030 |
Why?
|
Protein Conformation | 2 | 2006 | 4013 | 0.030 |
Why?
|
Catalysis | 1 | 1997 | 760 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1998 | 1676 | 0.030 |
Why?
|
Salmonella typhimurium | 1 | 1997 | 351 | 0.030 |
Why?
|
Dogs | 1 | 2000 | 3910 | 0.030 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2010 | 357 | 0.030 |
Why?
|
Models, Genetic | 2 | 2007 | 3493 | 0.030 |
Why?
|
Gene Frequency | 3 | 2008 | 3587 | 0.030 |
Why?
|
Immunoblotting | 1 | 1997 | 1683 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 2008 | 3058 | 0.030 |
Why?
|
Pulse Therapy, Drug | 1 | 2013 | 35 | 0.030 |
Why?
|
Heterozygote | 3 | 2007 | 2790 | 0.030 |
Why?
|
COS Cells | 2 | 2009 | 1160 | 0.030 |
Why?
|
Glycoproteins | 1 | 2002 | 2260 | 0.030 |
Why?
|
Hyperplasia | 1 | 1997 | 1183 | 0.030 |
Why?
|
Osteoporosis | 1 | 2003 | 1581 | 0.030 |
Why?
|
Dexamethasone | 1 | 2001 | 1949 | 0.030 |
Why?
|
Alopecia | 1 | 1997 | 381 | 0.030 |
Why?
|
Drug Resistance | 1 | 1999 | 1608 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2000 | 3847 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 2010 | 4933 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2003 | 2585 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4801 | 0.030 |
Why?
|
Cytokines | 1 | 2007 | 7317 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 1997 | 976 | 0.030 |
Why?
|
Blotting, Western | 1 | 2000 | 5180 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 1996 | 836 | 0.030 |
Why?
|
Gene Deletion | 1 | 2000 | 2751 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 1997 | 3133 | 0.030 |
Why?
|
Risk Factors | 2 | 2010 | 72145 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2012 | 62966 | 0.030 |
Why?
|
Prognosis | 1 | 2012 | 29010 | 0.020 |
Why?
|
Animals | 8 | 2009 | 168561 | 0.020 |
Why?
|
Fetus | 1 | 1998 | 1879 | 0.020 |
Why?
|
Fatal Outcome | 1 | 1996 | 1849 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1999 | 2014 | 0.020 |
Why?
|
DNA | 3 | 2010 | 7289 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 1996 | 781 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2000 | 6171 | 0.020 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2015 | 482 | 0.020 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 1996 | 1119 | 0.020 |
Why?
|
Azoospermia | 1 | 2010 | 27 | 0.020 |
Why?
|
Transcription Factors | 4 | 2019 | 12164 | 0.020 |
Why?
|
Aequorin | 1 | 2008 | 15 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 2935 | 0.020 |
Why?
|
Receptors, Retinoic Acid | 2 | 2000 | 232 | 0.020 |
Why?
|
Phosphotyrosine | 1 | 2009 | 457 | 0.020 |
Why?
|
Child | 4 | 2019 | 77478 | 0.020 |
Why?
|
Anovulation | 1 | 2008 | 58 | 0.020 |
Why?
|
DNA Mutational Analysis | 2 | 2008 | 4187 | 0.020 |
Why?
|
Protein Binding | 2 | 1997 | 9387 | 0.020 |
Why?
|
Estriol | 1 | 2007 | 54 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2019 | 77098 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 1996 | 2906 | 0.020 |
Why?
|
Body Weight | 1 | 1999 | 4664 | 0.020 |
Why?
|
Bone Density | 1 | 2000 | 3469 | 0.020 |
Why?
|
Cohort Studies | 5 | 2009 | 40450 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2009 | 599 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2384 | 0.020 |
Why?
|
Fibroblast Growth Factor 8 | 1 | 2007 | 61 | 0.020 |
Why?
|
Adipose Tissue | 1 | 1999 | 3278 | 0.020 |
Why?
|
Estrone | 1 | 2007 | 239 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2010 | 391 | 0.020 |
Why?
|
DNA-Binding Proteins | 3 | 2000 | 9639 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 1998 | 12958 | 0.020 |
Why?
|
Cricetulus | 1 | 2008 | 817 | 0.020 |
Why?
|
Child, Preschool | 2 | 2019 | 40955 | 0.020 |
Why?
|
Pregnancy | 3 | 2015 | 29087 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3740 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 1310 | 0.020 |
Why?
|
CHO Cells | 1 | 2008 | 1407 | 0.020 |
Why?
|
Mental Health | 1 | 2019 | 2997 | 0.020 |
Why?
|
Sex Factors | 1 | 1999 | 10392 | 0.020 |
Why?
|
Intra-Abdominal Fat | 1 | 2010 | 591 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 19223 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2008 | 732 | 0.020 |
Why?
|
Methods | 1 | 2005 | 1128 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2006 | 340 | 0.020 |
Why?
|
Cricetinae | 1 | 2008 | 2471 | 0.020 |
Why?
|
Organ Size | 1 | 2009 | 2253 | 0.020 |
Why?
|
Escherichia coli | 1 | 1996 | 4214 | 0.010 |
Why?
|
Syndrome | 1 | 2010 | 3248 | 0.010 |
Why?
|
Rats | 1 | 2000 | 24265 | 0.010 |
Why?
|
Age of Onset | 1 | 2010 | 3266 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2003 | 6454 | 0.010 |
Why?
|
Menstruation | 1 | 2005 | 299 | 0.010 |
Why?
|
Internationality | 1 | 2008 | 1002 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1737 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2007 | 2837 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2007 | 1526 | 0.010 |
Why?
|
Cryptorchidism | 1 | 2002 | 123 | 0.010 |
Why?
|
Testicular Hormones | 1 | 2002 | 188 | 0.010 |
Why?
|
Pituitary-Adrenal System | 1 | 2004 | 553 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 1792 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2008 | 1780 | 0.010 |
Why?
|
Genetic Variation | 2 | 2006 | 6540 | 0.010 |
Why?
|
Neoplasms | 1 | 2010 | 21596 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8333 | 0.010 |
Why?
|
Cleft Palate | 1 | 2006 | 558 | 0.010 |
Why?
|
Growth Inhibitors | 1 | 2002 | 385 | 0.010 |
Why?
|
Reference Standards | 1 | 2004 | 1020 | 0.010 |
Why?
|
Polymorphism, Genetic | 2 | 2001 | 4328 | 0.010 |
Why?
|
Transfection | 1 | 2008 | 5892 | 0.010 |
Why?
|
Proprotein Convertases | 1 | 2000 | 95 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1994 | 3336 | 0.010 |
Why?
|
Family Health | 1 | 2004 | 1282 | 0.010 |
Why?
|
Anti-Mullerian Hormone | 1 | 2002 | 399 | 0.010 |
Why?
|
Mass Screening | 1 | 1995 | 5238 | 0.010 |
Why?
|
Smell | 1 | 2001 | 243 | 0.010 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2000 | 311 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2001 | 642 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2000 | 20086 | 0.010 |
Why?
|
Operator Regions, Genetic | 1 | 1996 | 33 | 0.010 |
Why?
|
Hypertension | 1 | 1997 | 8455 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3862 | 0.010 |
Why?
|
DNA Footprinting | 1 | 1996 | 98 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 1995 | 5724 | 0.010 |
Why?
|
Operon | 1 | 1996 | 360 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2000 | 1179 | 0.010 |
Why?
|
X Chromosome | 1 | 1998 | 815 | 0.010 |
Why?
|
Renin | 1 | 1997 | 642 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4929 | 0.010 |
Why?
|
Biopsy | 1 | 2006 | 6756 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13256 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 9941 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 1997 | 965 | 0.010 |
Why?
|
Mice | 1 | 2000 | 81045 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 57683 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1998 | 2422 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14720 | 0.010 |
Why?
|
HIV Infections | 2 | 2010 | 16678 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9581 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1996 | 2024 | 0.010 |
Why?
|
Research Design | 1 | 2004 | 5979 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8621 | 0.000 |
Why?
|
Neurons | 1 | 2004 | 9325 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1996 | 5867 | 0.000 |
Why?
|
Blood Pressure | 1 | 1997 | 8541 | 0.000 |
Why?
|
United States | 1 | 2008 | 69693 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2000 | 35342 | 0.000 |
Why?
|